Free Trial
LON:INS

Instem (INS) Share Price, News & Analysis

Instem logo

About Instem Stock (LON:INS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
830
830
52-Week Range
N/A
Volume
3,800 shs
Average Volume
85,542 shs
Market Capitalization
£199.62 million
P/E Ratio
5,928.57
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Instem and its competitors with MarketBeat's FREE daily newsletter.

INS Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More Headlines

INS Stock Analysis - Frequently Asked Questions

Shares of INS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Instem investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
LON:INS
CIK
N/A
Fax
N/A
Employees
500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.14
Trailing P/E Ratio
5,928.57
Forward P/E Ratio
N/A
P/E Growth
1.89
Net Income
£3.34 million
Net Margins
5.50%
Pretax Margin
N/A
Return on Equity
6.35%
Return on Assets
4.62%

Debt

Debt-to-Equity Ratio
3.47
Current Ratio
0.95
Quick Ratio
0.84

Sales & Book Value

Annual Sales
£61.63 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
15.25
Book Value
GBX 239 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,050,000
Free Float
N/A
Market Cap
£199.62 million
Optionable
Not Optionable
Beta
0.42
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:INS) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners